Winter Park, FL, October 26, 2015 --(PR.com
)-- venVelo, one of the most active early-stage venture funds in central Florida, announced today it had approved additional investments in three of its current portfolio companies, Spectrum Bridge, Vigilant Biosciences, and Zentila. venVelo’s investments and those of its Board members in just these three companies now totals over $2 million.
“When we talk about ‘watering the flowers’, these three portfolio companies – and several of our others – epitomize this strategy,” said Allen H. Kupetz, COO and co-founder of venVelo. “We see strong management teams executing on sales forecasts and we want to continue to fuel their growth.”
venVelo’s other portfolio investments are Fattmerchant, flexReceipts, GENICON, Kairos, Knetik Media (which acquired Splyt), mCast Networks, and Thrive Frozen Nutrition.
venVelo, the premier early-stage no-fee venture fund in Florida for innovative companies seeking capital and mentoring, was launched in 2012 and quickly established itself as one of the most active venture funds in central Florida. It was named the 2014 “Tech Investor of the Year.” See http://www.venvelo.com/ for more information.